Related Experiment Video

Updated: Jun 5, 2026

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
07:38

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin

Published on: May 6, 2018

Nephrotic syndrome developing during induction chemotherapy for childhood acute lymphoblastic leukemia

Chanel Prestidge1, Shahrad Rod Rassekh2, Douglas G Matsell3

  • 1Division of Nephrology, Department of Pediatrics, British Columbia Children's Hospital, Level 4 Ambulatory Care Building, 4480 Oak Street, Vancouver, BC, V6H3V4, Canada. chanelprestidge@yahoo.com.

Clinical and Experimental Nephrology
|January 25, 2011
PubMed

Insights

Minimal change nephrotic syndrome can occur during acute lymphoblastic leukemia (ALL) induction chemotherapy in children. This finding supports immune cell dysregulation as a cause of nephrotic syndrome in ALL.

Area of Science:

  • Pediatric Oncology
  • Nephrology
  • Immunology

Background:

  • Acute lymphoblastic leukemia (ALL) is a common childhood cancer.
  • Nephrotic syndrome is a kidney disorder characterized by heavy protein loss in urine.
  • The relationship between ALL and nephrotic syndrome is not fully understood.

Observation:

  • This is the first report of minimal change nephrotic syndrome (MCNS) during induction chemotherapy for childhood ALL.
  • The patient developed MCNS while undergoing intensive cancer treatment.

Findings:

  • The occurrence of MCNS during ALL induction chemotherapy suggests a direct link.
  • This case supports the hypothesis that immune cell dysregulation is central to the pathogenesis of nephrotic syndrome in ALL patients.
  • It challenges the theory that the association is due to increased malignancy risk from prior immunosuppression for nephrotic syndrome.

Implications:

  • Understanding the pathogenesis of nephrotic syndrome in ALL is crucial for patient management.
  • This finding may influence treatment strategies and monitoring for kidney complications in children with ALL.
  • Further research into immune dysregulation in ALL is warranted.

More Related Videos

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia08:31

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on: October 17, 2025

Related Concept Videos

Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
Acute Pyelonephritis I: Introduction01:27

Acute Pyelonephritis I: Introduction

Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such as Proteus,...